The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
Official Title: Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
Study ID: NCT05553873
Brief Summary: This study aims to observe inflammatory biomarkers and their trend over the history of the disease in patients suffering from MPN Ph negative; it also wants to identify any correlations between the aforementioned biomarkers and disease outcomes, considering first of all the occurrence of thrombo-haemorrhagic events and the evolution in the accelerated / blast phase of the disease, shedding light on new tools that can potentially guarantee a prompt and better risk stratification
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Azienda Ospedaliera Universitaria Consorziale Policlinico, Bari, , Italy
Policlinico Sant'Orsola Malpighi, Bologna, , Italy
ASST Spedali Civili di Brescia, Brescia, , Italy
Policlinico Vittorio Emanuele, Catania, , Italy
Ospedale Universitario Federico II, Napoli, , Italy
Policlinico Umberto I, Università La Sapienza, Roma, , Italy
Azienda Ospedaliera Universitaria Città della Salute e delle Scienza, Torino, , Italy
Ospedale San Luigi di Orbassano - Ospedale Mauriziano, Torino, , Italy
Azienda Ospedaliera Universitaria Friuli Centrale, Udine, , Italy
Azienda Ospedaliera Universitaria Integrata, Verona, , Italy
Ospedale Belcolle, Viterbo, , Italy